Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 4 | IL-6 | 4535.0 | 83 | ||||
RA2159 | 4 | IL-6 | 4739.0 | 66 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | IL-6 | 1301.0 | 54 | ||||
N2645 | 4 | IL-6 | 1545.0 | 70 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | IL-6 | 1248.0 | 69 | ||||
RA2708 | 4 | IL-6 | 847.0 | 55 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 5357.0 | 51 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 14222.0 | 70 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 1493.0 | 71 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 4104.0 | 56 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 2762.0 | 63 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 6238.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 19862.0 | 71 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 26870.5 | 68 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 16559.0 | 59 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 32441.5 | 52 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 33012.5 | 52 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | IL-6 | 24611.0 | 69 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 5536.0 | 64 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 14436.0 | 59 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 1911.5 | 64 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 12073.5 | 86 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 2067.5 | 78 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 15424.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-6 | 36745.0 | 70 |